Newsroom

Newsroom

Diversey logo

Press Release

November 24, 2009
JohnsonDiversey, Inc. and Clayton Dubilier & Rice, LLC ("CD&R") today announced the completion of a previously announced agreement under which CD&R-managed funds are investing $477 million for an approximate 46 percent equity interest in...
NCI Building Systems

Press Release

October 20, 2009
NCI Building Systems, Inc. (NYSE: NCS) and Clayton, Dubilier & Rice, Inc. today announced the completion of the previously-announced $250 million equity investment in the Company by CD&R-managed funds. The CD&R-managed funds acquired...
Diversey logo

Press Release

October 7, 2009
JohnsonDiversey, Inc. and Clayton Dubilier & Rice, Inc. ("CD&R") today announced an agreement under which a CD&R-managed fund will invest $477 million for a 46 percent equity interest in the company as part of a broader recapitalization...
NCI Building Systems logo

Press Release

August 14, 2009
/PRNewswire-FirstCall/ - NCI Building Systems, Inc. (NYSE: NCS) today announced that it has entered into a definitive agreement with Clayton, Dubilier & Rice Fund VIII, L.P. (“the CD&R Fund”), a fund managed by Clayton, Dubilier & Rice,...

Press Release

July 14, 2009
Clayton, Dubilier & Rice today announced that seasoned consumer products, leisure and retail executive, Paul S. Pressler, has joined the Firm as an advisor. Mr. Pressler has extensive operating and consumer marketing experience in leading some...

Perspectives

January 16, 2009
In financing our portfolio companies, we want to ensure that management always has the balance sheet flexibility to execute long-term business building strategies even in challenging times.
The Masters of Private Equity and Venture Capital

Perspectives

January 1, 2009
In The Masters of Private Equity and Venture Capital, Robert Finkel aggregates management lessons from ten pioneers of private equity. The book is filled with colorful stories on the subjects that most matter to high-level investors, such as...

Media Coverage

Christian Rochat, Robert Quarta PQR, December 2008
December 1, 2008
A talk with Clayton, Dubilier & Rice’s Roberto Quarta & Christian Rochat
Private Equity International Awards 2007

Media Coverage

CD&R Receives 2007 North American LBO Firm of the Year Award Private Equity International
December 31, 2007
2007 has been an exceptionally productive year for CD&R in terms of realizations, new investments, creating value in the portfolio and building the organization. The Firm has announced realizations generating over $3 billion and deployed (or...

Perspectives

January 1, 2007
All private equity firms seek to maximize the value of their investments. However, there are many different models or routes to this end. What shall be referred to as the “industrial approach” in this chapter is a distinctive model which is based on...
Vera Whole Health Logo.

Press Release

February 17, 2022
Vera Whole Health, Inc. ("Vera") announced today that it has successfully completed its previously announced acquisition of Castlight Health, Inc. ("Castlight") at a price of $2.05 per share, net to the seller, in cash, without interest and subject...
Andrea Peiro

Press Release

February 9, 2022
Clayton, Dubilier & Rice announced the appointment of Andrea Peiro, an experienced technology professional and successful entrepreneur, as an Operating Principal. In his new role, Mr. Peiro will be engaged in evaluating investments and help...
Hand holding a seedling.

Perspectives

February 7, 2022
The conversation about private equity and environmental, social and corporate governance (ESG) has been largely around reporting guidelines and metrics. We believe private equity is well-positioned to drive and scale ESG best practices. The...
Anand Shah, M.D.

Press Release

February 3, 2022
Clayton, Dubilier & Rice today announced Anand Shah, M.D., former U.S. Food and Drug Administration (“FDA”) Deputy Commissioner for Medical and Scientific Affairs, as an Operating Advisor to CD&R funds. Dr. Shah will work with CD&R’s...
Vera Whole Health and Castlight Health logos

Press Release

January 5, 2022
Castlight Health, Inc. (“Castlight”) (NYSE: CSLT), a leading healthcare data and navigation company, and Vera Whole Health, Inc. (“Vera”), a pioneer in advanced primary care, today jointly announced an agreement under which the companies will...
Jon Selib Headshot

Press Release

December 21, 2021
Clayton, Dubilier & Rice today announced the appointment of Jon Selib, former Senior Vice President of Global Policy & Public Affairs at Pfizer, as Managing Director and Global External Affairs Leader. In his new role, which will take effect...
Belron logo

Press Release

December 17, 2021
Clayton, Dubilier & Rice Fund X today announced the sale of its investment in Belron, a worldwide leader in vehicle glass repair and replacement. The two-part transaction included the sale of approximately 39% of CD&R Fund X’s stake to funds...
Gordon Riske

Press Release

December 13, 2021
Clayton, Dubilier & Rice announced today that Gordon Riske will be engaged as an Operating Advisor to CD&R funds effective January 1, 2022 after he steps down as Chief Executive Officer of KION GROUP AG, a global provider of materials...

Events

December 7, 2021
CD&R Chairman Don Gogel joined Professor Florin Vasvari, Academic Director of the Institute of Entrepreneurship and Private Capital (IEPC), in a London Business School fireside chat titled, “In conversation with Don Gogel: private capital in...
Screen shot from video
Play Video

Events

December 7, 2021
CD&R Chairman Don Gogel discusses trends and opportunities in private capital with Professor Florin Vasvari, Academic Director of the Institute of Entrepreneurship and Private Capital (IEPC) at London Business School. The video below...
Certain persons quoted in certain news items are advisors to CD&R’s funds or executives, employees, directors or persons serving in similar capacities in CD&R’s funds’ portfolio companies, or other persons or organizations who have or may in the future have business or other relationships with CD&R or its funds. Such relationships and any compensation associated with them create a conflict of interest, as the relationship and/or the compensation incentivizes such person to endorse CD&R or its funds.